The Business Brew cover image

Current Events - uniQure and the FDA

The Business Brew

00:00

Neurofilament biomarker trends after treatment

Tabrizi discusses CSF neurofilament declines suggesting reduced neural injury in treated cohorts.

Play episode from 34:22
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app